The Role of Fibrinolytic System in Health and Disease

This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O’Connel...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Materiálatiipa: Online
Giella:eaŋgalasgiella
Almmustuhtton: MDPI - Multidisciplinary Digital Publishing Institute 2022
Fáttát:
Liŋkkat:ONIX_20220706_9783036546193_136
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
_version_ 1869518564975706112
collection Directory of Open Access Books
description This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O’Connell; receptor of urokinase type plasminogen activator, by Dr. M. Ploug et al.; tissue plasminogen activator induction in purjinjen neuron, by Dr. Seeds; fibrinolysis from the blood to the brain, by Dr. Robert Metcalf; tissue plasminogen activator induces the opening of the blood–brain barrier, by Dr. M. Yepes; fibrinolysis shutdown in trauma: a historical review and clinical application, by Drs. Hunter Moore and Ernest Moore; fibrinolysis in immunity, by Drs. K. Kolev and Robert Medcalf; the role of plasminogen activator inhibitor 1, by Drs. M. Erin, A.E. Boe, and E.A. Klyachko; and finally, persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients, by J.P. Meizoso.
format Online
id doab-20.500.12854ir-87541
institution Directory of Open Access Books
language eng
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-875412024-03-28T03:33:23Z The Role of Fibrinolytic System in Health and Disease Kwaan, Hau C. COVID-19 fibrinolysis renin-aldosterone-angiotensin-system (RAAS) plasminogen activator inhibitor 1 (PAI-1) urokinase plasminogen activator urokinase plasminogen activator receptor plasminogen activator inhibitor-1 acute lung injury and repair and pleural injury and pleural organization PAI-1 cardiovascular disease cancer inflammation fibrosis aging obstructive sleep apnoea OSA coagulation platelets brown adipose tissue obesity plasminogen activation immune response thrombin activatable fibrinolysis inhibitor TAFI proCPU proCPB proCPR carboxypeptidase uPA uPAR PA system tissue-type plasminogen activator (tPA) urokinase-type plasminogen activator (uPA) neurodegeneration thrombin shear clot retraction Factor XIII clot stability NETs plasmin plasminogen activator PAI-2 antiplasmin thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O’Connell; receptor of urokinase type plasminogen activator, by Dr. M. Ploug et al.; tissue plasminogen activator induction in purjinjen neuron, by Dr. Seeds; fibrinolysis from the blood to the brain, by Dr. Robert Metcalf; tissue plasminogen activator induces the opening of the blood–brain barrier, by Dr. M. Yepes; fibrinolysis shutdown in trauma: a historical review and clinical application, by Drs. Hunter Moore and Ernest Moore; fibrinolysis in immunity, by Drs. K. Kolev and Robert Medcalf; the role of plasminogen activator inhibitor 1, by Drs. M. Erin, A.E. Boe, and E.A. Klyachko; and finally, persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients, by J.P. Meizoso. 2022-07-06T11:55:13Z 2022-07-06T11:55:13Z 2022 book ONIX_20220706_9783036546193_136 9783036546193 9783036546209 https://directory.doabooks.org/handle/20.500.12854/87541 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/5739 https://mdpi.com/books/pdfview/book/5739 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-4620-9 10.3390/books978-3-0365-4620-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036546193 9783036546209 170 Basel open access
spellingShingle COVID-19
fibrinolysis
renin-aldosterone-angiotensin-system (RAAS)
plasminogen activator inhibitor 1 (PAI-1)
urokinase plasminogen activator
urokinase plasminogen activator receptor
plasminogen activator inhibitor-1
acute lung injury and repair and pleural injury and pleural organization
PAI-1
cardiovascular disease
cancer
inflammation
fibrosis
aging
obstructive sleep apnoea
OSA
coagulation
platelets
brown adipose tissue
obesity
plasminogen activation
immune response
thrombin activatable fibrinolysis inhibitor
TAFI
proCPU
proCPB
proCPR
carboxypeptidase
uPA
uPAR
PA system
tissue-type plasminogen activator (tPA)
urokinase-type plasminogen activator (uPA)
neurodegeneration
thrombin
shear
clot retraction
Factor XIII
clot stability
NETs
plasmin
plasminogen activator
PAI-2
antiplasmin
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
The Role of Fibrinolytic System in Health and Disease
title The Role of Fibrinolytic System in Health and Disease
title_full The Role of Fibrinolytic System in Health and Disease
title_fullStr The Role of Fibrinolytic System in Health and Disease
title_full_unstemmed The Role of Fibrinolytic System in Health and Disease
title_short The Role of Fibrinolytic System in Health and Disease
title_sort role of fibrinolytic system in health and disease
topic COVID-19
fibrinolysis
renin-aldosterone-angiotensin-system (RAAS)
plasminogen activator inhibitor 1 (PAI-1)
urokinase plasminogen activator
urokinase plasminogen activator receptor
plasminogen activator inhibitor-1
acute lung injury and repair and pleural injury and pleural organization
PAI-1
cardiovascular disease
cancer
inflammation
fibrosis
aging
obstructive sleep apnoea
OSA
coagulation
platelets
brown adipose tissue
obesity
plasminogen activation
immune response
thrombin activatable fibrinolysis inhibitor
TAFI
proCPU
proCPB
proCPR
carboxypeptidase
uPA
uPAR
PA system
tissue-type plasminogen activator (tPA)
urokinase-type plasminogen activator (uPA)
neurodegeneration
thrombin
shear
clot retraction
Factor XIII
clot stability
NETs
plasmin
plasminogen activator
PAI-2
antiplasmin
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
topic_facet COVID-19
fibrinolysis
renin-aldosterone-angiotensin-system (RAAS)
plasminogen activator inhibitor 1 (PAI-1)
urokinase plasminogen activator
urokinase plasminogen activator receptor
plasminogen activator inhibitor-1
acute lung injury and repair and pleural injury and pleural organization
PAI-1
cardiovascular disease
cancer
inflammation
fibrosis
aging
obstructive sleep apnoea
OSA
coagulation
platelets
brown adipose tissue
obesity
plasminogen activation
immune response
thrombin activatable fibrinolysis inhibitor
TAFI
proCPU
proCPB
proCPR
carboxypeptidase
uPA
uPAR
PA system
tissue-type plasminogen activator (tPA)
urokinase-type plasminogen activator (uPA)
neurodegeneration
thrombin
shear
clot retraction
Factor XIII
clot stability
NETs
plasmin
plasminogen activator
PAI-2
antiplasmin
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
url ONIX_20220706_9783036546193_136